SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001021408-03-005171
Filing Date
2003-03-27
Accepted
2003-03-27 17:01:11
Documents
10
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1326379
3 AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF REORGANIZATION dex22.txt EX-2.2 12362
4 REGISTRANT'S ARTICLES OF AMENDMENT TO RESTATED ARTICLES OF INCORPORATION dex32.txt EX-3.2 24898
5 INDENTURE BETWEEN THE REGISTRANT AND STATE STREET BANK AND TRUST CO. dex44.txt EX-4.4 292087
6 LEASE AGREEMENT BETWEEN ELLIOTT PARK LLC AND THE REGISTRANT dex107.txt EX-10.7 500992
7 EMPLOYMENT AGREEMENT BETWEEN THE REGISTRANT AND JAMES A. BIANCO dex109.txt EX-10.9 24512
8 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 26179
9 SUBSIDIARIES OF THE REGISTRANT dex211.txt EX-21.1 403
10 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS. dex231.htm EX-23.1 2110
11 CERTIFICATION dex991.htm EX-99.1 7473
  Complete submission text file 0001021408-03-005171.txt   2220131
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12465 | Film No.: 03621622
SIC: 2834 Pharmaceutical Preparations